Withanolide A is a major steroidal lactone (withanolide) isolated from the medicinal plant *Withania somnifera* (Ashwagandha). It is a C28 steroidal lactone built on an ergostane skeleton, characterized by a δ-lactone ring attached at C-22 and C-26. This compound is a key bioactive marker for the quality of Ashwagandha extracts. Its primary applications are in biomedical research and nutraceuticals due to its potent pharmacological activities. Withanolide A exhibits significant anti-inflammatory, immunomodulatory, and neuroprotective effects. It is studied for its potential in managing neurodegenerative disorders (like Alzheimer's and Parkinson's disease), cancer (through induction of apoptosis and inhibition of angiogenesis), and as an adaptogen to combat stress. The mechanisms involve modulation of various signaling pathways, including NF-κB and Nrf2. As a natural product lead compound, Withanolide A serves as a reference standard in analytical chemistry for the authentication and standardization of Ashwagandha-based products. Its supply is primarily driven by demand from the dietary supplement, herbal medicine, and pharmaceutical research sectors.